1. Amyloid in bone marrow smears in systemic light-chain amyloidosis. (2nd January 2017) Authors: Kimmich, Christoph; Schönland, Stefan; Kräker, Sandra; Andrulis, Mindaugas; Ho, Anthony D.; Mayer, Gudrun; Dittrich, Tobias; Hundemer, Michael; Hegenbart, Ute Journal: Amyloid Issue: Volume 24:Number 1(2017) Page Start: 52 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Immune responses to WT1 in patients with AML or MDS after chemotherapy and allogeneic stem cell transplantation. Issue 7 (27th November 2015) Authors: Casalegno‐Garduño, Rosaely; Schmitt, Anita; Spitschak, Alf; Greiner, Jochen; Wang, Lei; Hilgendorf, Inken; Hirt, Carsten; Ho, Anthony D.; Freund, Mathias; Schmitt, Michael Journal: International journal of cancer Issue: Volume 138:Issue 7(2016:Apr. 01) Page Start: 1792 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Quantification of number of CD38 sites on bone marrow plasma cells in patients with light chain amyloidosis and smoldering multiple myeloma. Issue 5 (20th April 2018) Authors: Kriegsmann, Katharina; Dittrich, Tobias; Neuber, Brigitte; Awwad, Mohamed H. S.; Hegenbart, Ute; Goldschmidt, Hartmut; Hillengass, Jens; Hose, Dirk; Seckinger, Anja; Müller‐Tidow, Carsten; Ho, Anthony D.; Schönland, Stefan; Hundemer, Michael Journal: Cytometry Issue: Volume 94:Issue 5(2018) Page Start: 767 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Efficacy and toxicity of a rituximab and methotrexate based regimen (GMALL B-ALL/NHL 2002 protocol) in high risk diffuse large cell B-cell lymphoma patients as a first line treatment. Issue 7 (2nd July 2016) Authors: Schwarzbich, Mark-Alexander; Schöning, Tilman; Cremer, Martin; Lisenko, Katharina; Ho, Anthony D.; Witzens-Harig, Matthias Journal: Leukemia & lymphoma Issue: Volume 57:Issue 7(2016:Jul.) Page Start: 1723 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. TP53 mutation in patients with high‐risk acute myeloid leukaemia treated with allogeneic haematopoietic stem cell transplantation. (13th January 2016) Authors: Middeke, Jan M.; Herold, Sylvia; Rücker‐Braun, Elke; Berdel, Wolfgang E.; Stelljes, Matthias; Kaufmann, Martin; Schäfer‐Eckart, Kerstin; Baldus, Claudia D.; Stuhlmann, Reingard; Ho, Anthony D.; Einsele, Hermann; Rösler, Wolf; Serve, Hubert; Hänel, Mathias; Sohlbach, Kristina; Klesse, Christian; M... Journal: British journal of haematology Issue: Volume 172:Number 6(2016) Page Start: 914 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Expression of CDKN1C in the bone marrow of patients with myelodysplastic syndrome and secondary acute myeloid leukemia is associated with poor survival after conventional chemotherapy. Issue 6 (3rd June 2016) Authors: Radujkovic, Aleksandar; Dietrich, Sascha; Andrulis, Mindaugas; Benner, Axel; Longerich, Thomas; Pellagatti, Andrea; Nanda, Kriti; Giese, Thomas; Germing, Ulrich; Baldus, Stefan; Boultwood, Jacqueline; Ho, Anthony D.; Dreger, Peter; Luft, Thomas Journal: International journal of cancer Issue: Volume 139:Issue 6(2016:Sep. 15) Page Start: 1402 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Dose‐intensified bendamustine followed by autologous peripheral blood stem cell support in relapsed and refractory multiple myeloma with impaired bone marrow function. Issue 4 (18th March 2015) Authors: Breitkreutz, Iris; Becker, Natalia; Benner, Axel.; Kosely, Florentina; Heining, Christoph; Hillengass, Jens; Egerer, Gerlinde; Ho, Anthony D.; Goldschmidt, Hartmut; Raab, Marc S. Journal: Hematological oncology Issue: Volume 34:Issue 4(2016:Dec.) Page Start: 200 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Rituximab maintenance improves survival in male patients with diffuse large B‐cell lymphoma. Results of the HD2002 prospective multicentre randomized phase III trial. (9th October 2015) Authors: Witzens‐Harig, Mathias; Benner, Axel; McClanahan, Fabienne; Klemmer, Jennifer; Brandt, Julia; Brants, Elke; Rieger, Michael; Meissner, Julia; Hensel, Manfred; Neben, Kai; Dreger, Peter; Lengfelder, Eva; Schmidt‐Wolf, Ingo; Krämer, Alwin; Ho, Anthony D. Journal: British journal of haematology Issue: Volume 171:Number 5(2015:Dec.) Page Start: 710 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Submyeloablative total body irradiation‐based conditioning and allogeneic stem cell transplantation in high‐risk myeloma with early progression after up‐front autologous transplantation. (24th August 2021) Authors: Mai, Elias K.; Schmitt, Thomas; Radujkovic, Aleksandar; König, Laila; Goldschmidt, Hartmut; Ho, Anthony D.; Luft, Thomas; Müller‐Tidow, Carsten; Dreger, Peter; Hegenbart, Ute; Schönland, Stefan O. Journal: British journal of haematology Issue: Volume 196:Number 1(2022) Page Start: 244 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. The mTOR Inhibitor Temsirolimus Added to Rituximab Combined With Dexamethasone, Cytarabine, and Cisplatinum (R-DHAP) for the Treatment of Patients With Relapsed or Refractory DLBCL – Results From the Phase-II STORM Trial. Issue 10 (23rd October 2021) Authors: Witzens-Harig, Mathias; Viardot, Andreas; Keller, Ulrich; Wosniok, Julia; Deuster, Oliver; Klemmer, Jennifer; Geueke, Anne-Marie; Meißner, Julia; Ho, Anthony D.; Atta, Johannes; Marks, Reinhard; La Rosée, Paul; Buske, Christian; Dreyling, Martin H.; Hess, Georg Journal: HemaSphere Issue: Volume 5:Issue 10(2021) Page Start: e636 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗